Novartis Institutes for Biomedical Research, Basel-Stadt, Switzerland
Christian Bergsdorf, PhD
Novartis Institutes for BioMedical Research, Chemical Biology and Therapeutics, Protein Sciences, Basel; Switzerland
Since 1999, Dr. Christian Bergsdorf has been working in the different academic, Biotech and big pharma research institutes, focusing on mechanistic protein characterization and development/ implementation of new biochemical/biophysical assay techniques in the early lead discovery process. In 2008, he joined the Biophysics group in Novartis Basel as a laboratory head. In his function, he applied and tailored biophysical methods for their usage in early lead finding/validation and MoA studies to get a deeper understanding about target-ligand interactions. Besides, he evaluated and implemented new biophysical approaches in early lead discovery to enable higher throughput biophysics and to tackle difficult targets as membrane proteins, protein complexes, nucleic acids.
Disclosure information not submitted.
Sunday, February 6, 2022
8:30 AM – 4:30 PM